Impact of French Medicines Agency's communication on sodium valproate prescription in women of childbearing potential age

A. Degremont 1 B. Le Nautout 1 C. Rault 2 E. Oger 2 A. Biraben 2, 3 E. Polard 2 E. Nowak 4, 5
1 REPERES - Recherche en Pharmaco-épidémiologie et Recours aux Soins
2 CHU Pontchaillou [Rennes]
3 LTSI - Laboratoire Traitement du Signal et de l'Image
4 CHU - BREST - Hôpital de la Cavale Blanche - CHRU Brest
5 CIC Brest
Document type :
Journal articles
Complete list of metadatas
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01833091
Contributor : Laurent Jonchère <>
Submitted on : Monday, July 9, 2018 - 1:32:19 PM
Last modification on : Wednesday, July 11, 2018 - 1:17:05 AM

Identifiers

  • HAL Id : hal-01833091, version 1

Collections

UNIV-RENNES1 | LTSI | REPERES | UNIV-BREST | UR1-UFR-SVE | EHESP | UNIV-RENNES | USPC

Citation

A. Degremont, B. Le Nautout, C. Rault, E. Oger, A. Biraben, et al.. Impact of French Medicines Agency's communication on sodium valproate prescription in women of childbearing potential age. Fundamental and Clinical Pharmacology, Wiley, 2018, 32, pp.6-6. ⟨hal-01833091⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

36